Source: London Stock Exchange plc.

Curidium Medica - Director/PDMR Shareholding

London--(Marketwire - May 20, 2008) -

Curidium Medica plc ("Curidium" or the "Company")

Curidium Announces Director's Purchase of Company Shares 

LONDON, UK, 20 May 2008, Curidium Medica plc, (LSE: CUR), a personalized
medicine company focused on bringing the right drug to the right
patient, announced today that director Rob Smith, Finance Director,
today has purchased 1,825 ordinary shares in the Company at a price of
54.8 pence per share. 

Following this transaction, Rob Smith is interested
in 8,491 shares representing approximately 0.046 per cent of the
Company's total issued share capital.

- END -

For further information, please contact:

Rob Smith                                           +44 (0)20 7383 5345

Finance Director, Curidium Medica plc

Charlie Cunningham                                  +44 (0)20 7600 1658

JM Finn Capital Markets Ltd

Billy Clegg / Edward Westropp / Annie Evangeli     + 44 (0)20 7831 3113

Financial Dynamics

                    This information is provided by RNS
          The company news service from the London Stock Exchange


Contact Information: Contacts: RNS Customer Services 0044-207797-4400